Not finding it? Sign in to also search OpenAlex live.
-
Belzutifan (bel) plus lenvatinib (lenva) versus cabozantinib (cabo) for advanced renal cell carcinoma (RCC) after anti–PD-(L)1 therapy: Open-label phase 3 LITESPARK-011 study.
Robert John Motzer, Se Hoon Park, Ray McDermott, Camillo Porta, Daniel Yick Chin Heng, Mauricio Burotto, +12 more
13citations -
Unmet need for patients with metastatic triple-negative breast cancer initiating first-line treatment: data from the prospective German tumor registry OPAL2026 ESMO Real World Data and Digital Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
E. Stickeler, T. Decker, M-O. Zahn, M.A.M. Thill, M. Zaiss, A. Nusch, +9 more
0citations -
Body Composition in Cholangiocarcinoma Affects Immune Cell Populations in the Tumor and Normal Liver Parenchyma2024 Journal of Clinical and Experimental Hepatology article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Dong Liu, Tarick M. Al‐Masri, Carlos Constantin Otto, Jens Thomas Siveke, Sven Arke Lang, Tom Florian Ulmer, +6 more
1citations -
Body composition in cholangiocarcinoma affects immune cell populations in the tumor and normal liver parenchyma2024 Zeitschrift für Gastroenterologie article Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Dong Liu, Tarick M. Al‐Masri, Carlos Constantin Otto, Jens Thomas Siveke, Sven Arke Lang, Tom Florian Ulmer, +6 more
0citations -
Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models2023 Journal of Clinical Investigation article Medicine Cancer Immunotherapy and Biomarkers Open access
Xinjun Lu, Jiejie Xu, Benjamin L. Green, Honghua Zhang, Guofei Cui, Yi Zhang, +10 more
40citations -
9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial
Elena Hartmann, Helen Goergen, Paul Jan Bröckelmann, Anja Mottok, Tabea Steinmüller, Johanna Grund, +10 more
23citations -
ISA101 and nivolumab for HPV-16 + cancer: updated clinical efficacy and immune correlates of response2022 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Luana Guimarães de Sousa, Kimal Rajapakshe, Jaime Rodriguez Canales, Renee L. Chin, Lei Feng, Qi Wang, +12 more
98citations -
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors2020 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Aung Naing, Justin F. Gainor, Hans A. J. Gelderblom, Patrick M. Forde, Marcus Otho Butler, Chia‐Chi Lin, +11 more
86citations -
TIGIT drives the immunosuppressive environment by downregulation of metalloproteinases MMP2 and MMP14 in perihilar cholangiocarcinoma2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cholangiocarcinoma and Gallbladder Cancer Studies Open access
Lara Rosaline Heij, Konrad Reichel, Willem de Koning, Jan Bednarsch, Xiuxiang Tan, Julia Campello Deierl, +13 more
0citations -
IFNγ-Stimulated B Cells Inhibit T Follicular Helper Cells and Protect Against Atherosclerosis2022 Frontiers in Cardiovascular Medicine article Immunology and Microbiology Atherosclerosis and Cardiovascular Diseases Open access
Hidde Douna, Jill de Mol, Jacob Amersfoort, Frank H. Schaftenaar, Máté G. Kiss, Bianca E Suur, +6 more
7citations -
Gut microbiota mediates trafficking of intestinal T cells to the brain to exacerbate neuroinflammation after ischemic stroke2025 Research Square preprint Neuroscience Neuroinflammation and Neurodegeneration Mechanisms Open access
Zhuang Li, Nannan Guo, Xiangyu Zuo, Jinlian Shao, Fabing Zhang, Yu Xiao, +19 more
0citations -
Tumour-derived factors prime microglia for immune checkpoint-mediated T-cell regulation2026 bioRxiv (Cold Spring Harbor Laboratory) preprint Neuroscience Neuroinflammation and Neurodegeneration Mechanisms Open access
Luca D Schreurs, Jessica Barz, Trong-Hieu Nguyen, Jule Schmedding, Liudmila Lobastova, Patrick Hoelker, +9 more
0citations -
OPTIM: a randomized phase II trial of nivolumab followed by nivolumab-ipilimumab or docetaxel at progression in recurrent/metastatic squamous cell carcinoma of the head and neck (OPTIM; AIO-KHT-0117)
Viktor Grünwald, Jurgen Alt, Mareike Tometten, Mathias Hänel, Philipp Ivanyi, Gunter Schuch, +7 more
0citations -
Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent/metastatic HPV16-positive head and neck cancer
Caroline Even, Kevin Joseph Harrington, Erminia Massarelli, Simon A. Laban, Jérôme Fayette, Marc Oliva, +15 more
11citations -
Blood-based kinase activity profiling to predict response to immune checkpoint inhibitors in patients with advanced stage NSCLC: the prospective IOpener study2026 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access
Karlijn de Joode, Harry J.M. Groen, Michel M. van den Heuvel, Jeroen S. Kloover, Femke S. van der Meer, Cor H. van der Leest, +12 more
0citations